Genome Screening

StoreGene provides comprehensive whole-genome screening across all 22,000 genes, identifying variants with known links to human disease. Our approach enables earlier detection, proactive management, and more personalised healthcare.

We offer two levels of screening to suit different needs:

Actionable Screening

Our Actionable Screening focuses on genetic conditions for which there are established treatment pathways. These are conditions with:

• Clearly defined features

• Opportunities for early detection

• Reliable genetic tests

• Proven interventions or treatment options

This screening empowers individuals and healthcare providers to take immediate, evidence-based action when needed.

Comprehensive Screening

Our Comprehensive Screening includes all variants strongly associated with human disease, even when current guidelines do not offer clear treatment or management pathways.
This includes complex or late-onset neurological conditions, such as Alzheimer’s disease or Parkinson’s disease, where awareness is essential for long-term planning and risk management.

Both screening options include analysis for common high-impact genetic conditions such as Hereditary Hemochromatosis (genetically elevated iron levels).

The goal of genome screening is to deliver meaningful benefits by helping people prevent or better manage health conditions, while also giving healthcare providers powerful tools for personalised treatment. It empowers individuals with the knowledge and confidence they need to take control of their long-term health.

StoreGene’s whole-genome screening brings precision medicine within reach, affordable, accessible, and actionable.

Requirements: Blood Sample or Transfer of Whole Genome Data

Sequencing Time: 30 days

Analysis Time: 24 hours